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Background: Asthma is an allergic inflammatory disease of the airways. The inter-
action between bronchial epithelial cells and eosinophils is an important feature of 
an asthma attack. Eotaxin, an eosinophil-specific C-C chemokine, is a potent chemo-
attractant involved in the mobilization of eosinophils into the airway after allergic 
stimulation. Cnidii monnieri fructus, the dried fruit of Cnidium monnieri Cusson, 
has been used as an antipruritogenic agent in ancient China. Osthol is the major 
component of Cnidii monnieri fructus extract. We investigated the ability of osthol 
to regulate cytokine-induced eotaxin expression in the human bronchial epithelial 
cell line BEAS-2B.
Methods: BEAS-2B cells were pretreated with osthol at different concentrations 
(0.1−10 μM), and then stimulated with interleukin (IL)-4 alone, or in combination 
with tumor necrosis factor (TNF)-α. Eotaxin levels were determined by real-time 
reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent 
assay. STAT6 (signal transducer and activator of transcription 6) and MAPK (mitogen-
activated protein kinase) expressions were evaluated by Western blotting, to detect 
possible intracellular signal transduction.
Results: IL-4 and TNF-α significantly induced eotaxin expression in BEAS-2B cells. 
Expression of eotaxin was suppressed by osthol (0.1−10 μM) in a dose-dependent 
manner. Osthol did not suppress IL-4-induced p38, ERK or JNK expression. Osthol 
did suppress IL-4-induced STAT6 in a dose-dependent manner.
Conclusion: Osthol suppressed IL-4-induced eotaxin in BEAS-2B cells via inhibition 
of STAT6 expression. This data suggest that osthol might have potential for treating 
allergic airway inflammation.
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1. Introduction
Some people prefer to use traditional Chinese herbs 
to treat or stabilize asthma, instead of visiting phy-
sicians. Osthol (7-methoxy-8-isopentenoxycoumarin), 
an active constituent of coumarin derivatives, has 
been extracted from many medicinal plants such 
as Cnidium monnieri and Angelica pubescens. These 
plants are used in traditional Chinese medicine as 
external preparations for the treatment of eczema, 
cutaneous pruritus, and Trichomonas vaginalis infec-
tion.1 Recent pharmacological studies have revealed 
that osthol may have antiproliferative,2 vasore-
laxant,1 antihepatitis,3 anti-inflammatory,4 anti-
microbacterial5 and antiallergic effects.6 Although 
osthol has been shown to be valuable for many clini-
cal applications, very few data are available con-
cerning its effect in allergic asthma.
Asthma is defined as an obstructive disease of the 
pulmonary airways resulting from spasms of airway 
muscle, increased mucus secretion, and inflamma-
tion.7 Evidence shows that cell-to-cell interactions 
play an important role in airway hyperreactivity 
caused by inflammatory cascades, resulting in the 
clinical symptoms of asthma.8 The consequent in-
flux and activation of granulocytes, including eosi-
nophils and neutrophils, possibly T lymphocytes, 
basophils, and platelets, and the subsequent infil-
tration of monocytes and macrophages, may be re-
sponsible for the continuing inflammatory reaction, 
airway hyperresponsiveness, and active bronchial 
asthma.9 Most evidence suggests that eosinophils are 
the most important granulocytes in these responses, 
and that eosinophilic infiltration and activation may 
account for the unique, spasmodic, and cyclic nature 
of hyperreactive airways.10 The mechanisms under-
lying the selective recruitment of eosinophils are 
complex, and include multistep processes, probably 
mediated by the cooperative action between cyto-
kines that cause eosinophil priming and increased 
survival (interleukin [IL]-3, IL-5, granulocyte-
macrophage colony stimulating factor) and those 
that activate the endothelium (IL-1, tumor ne-
crosis factor [TNF]-α, IL-4, IL-13), and eosinophil-
selective chemoattractant molecules, especially 
C-C chemokines.11
Eotaxin is a C-C chemokine implicated in the 
recruitment of eosinophils in a variety of inflam-
matory disorders and, unlike all other eosinophil 
chemoattractants, is eosinophil-specific.12 This 
characterizes eotaxin as a key mediator in allergic 
diseases of which eosinophilic infiltration is char-
acteristic.13 Cultured bronchial epithelial cells, in-
cluding normal bronchial epithelium, have been 
observed to produce eotaxin after stimulation with 
TNF-α and T helper (Th) type 2 cytokines.14
No data are available on the influence of osthol 
on eotaxin expression in bronchial epithelial cells 
in vitro. We investigated the ability of osthol to 
suppress eotaxin expression stimulated by the Th2 
cytokine IL-4 alone, or in combination with TNF-α, 
and explored the possible mechanisms whereby 
osthol can regulate eotaxin expression.
2. Methods
2.1. Cell culture
Human bronchial epithelial BEAS-2B cells (American 
Type Culture Collection, Rockville, MD, USA) were 
cultured in RPMI-1640 medium (Invitrogen, Gibco, 
Carlsbad, CA, USA) supplemented with 10% fetal 
bovine serum (FBS) (Gibco), 100 U/mL penicillin, 
100 μg/mL streptomycin and 0.25 μg/mL amphoter-
icin B (Gibco) at 37ºC in 5% CO2 in a humidified in-
cubator. Cells were centrifuged and resuspended 
in fresh media in 12-well plates at a concentration 
of 5 × 105/mL or in 100-mm dishes at a concentration 
of 5 ×106/mL for 12 hours before experimental use.
2.2. Stimulation of the cells
When BEAS-2B cells reached 80% confluence in the 
12-well plates and 100-mm dishes prepared for 
enzyme-linked immunosorbent assay (ELISA) and 
Western blot, respectively, the culture medium was 
replaced with RPMI-1640 without FBS. The rea-
gents used were osthol, purchased from Wako Pure 
Chemicals (Osaka, Japan), and recombinant human 
TNF-α and IL-4, purchased from R&D Systems 
(Minneapolis, MN, USA). The cells were then pre-
treated with different concentrations of osthol 
(0.1 μM, 1 μM, 10 μM) for 2 hours before stimulation 
with IL-4 (20 ng/mL) alone, or IL-4 (10 ng/mL) com-
bined with TNF-α (10 ng/mL). Cell supernatants were 
collected after 48 hours for ELISA of eotaxin.
2.3. ELISA
Culture supernatants were used to detect the pro-
duction of eotaxin using sandwich ELISA from R&D 
Systems, performed according to the manufactur-
er’s instructions. Absorbance was measured at 
450 nm using a microplate reader (Thermo Fisher 
Scientific, Inc., Waltham, MA, USA).
2.4.  RNA extraction and real-time 
polymerase chain reaction (PCR)
Total RNA from the cells was cleaned using RNeasy 
Mini Kits (Qiagen, Hilden, Germany) according to the 
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manufacturer’s instructions. Three micrograms of RNA 
from each sample was reverse-transcribed to first-
strand cDNA in 20 μL of reaction mixture using a 
SuperScript™ First-Strand Synthesis System for reverse 
transcription (RT)-PCR kit (Invitrogen). Quantitative 
analysis was performed using the ABI PRISM 9700 
HT sequence detection system (Applied Biosystems, 
Foster City, CA, USA) using the predeveloped Taqman 
probe/primer combination for eotaxin (sequence of 
primers: F, gagcaggaaagaacagggaagact; R, atgggca-
caggattagagacagc). Taqman PCR was performed in 
10-μL volumes using AmpliTaq Gold polymerase and 
universal master mix (Applied Biosystems). Threshold 
cycle numbers were transformed using the Ct 
(threshold cycle) and relative value methods, as de-
scribed by the manufacturer, and were expressed 
relative to β-actin, which was used as a house-
keeping gene by multiplexing single reactions.
2.5. Western blot analysis
Pretreatment, with or without osthol at three differ-
ent concentrations (0.1 μM, 1 μM, 10 μM), was con-
ducted for 2 hours. The cells were then stimulated 
with IL-4 (20 ng/mL) for 30 minutes. Total cell extracts 
were prepared in equal volumes of ice-cold 150-μL 
lysis buffer on ice for at least 1 hour, and samples 
were then centrifuged at 12,000 g for 10 minutes. 
Supernatants of total protein were harvested for 
Western blot assays. Cells treated with osthol for 
the indicated times were lysed, and the protein 
concentrations were determined using a Hoefer 
protein assay (Amersham Biosciences, Piscataway, 
NJ, USA). For Western blotting, 20 μg of cell total 
protein was loaded into each well for sodium do-
decyl sulfate-polyacrylamide gel electrophoresis. 
The protein was transferred to polyvinylidene difluo-
ride membranes using transfer buffer (25 mM Tris, 
192 mM glycine, and 10% methanol) at 100 V for 2 
hours. The membranes were incubated with block-
ing buffer (125 mM NaCl, 2.5 mM KCl, 25 mM Tris, 
pH 7.4) for 1 hour. The blot was then incubated over-
night at 4ºC with primary antibodies (rabbit anti-
human antibody) to JNK, phosphorylated JNK, p38, 
and phosphorylated p38 (Cell Signaling Technology 
Inc., Beverly, MA, USA), and STAT6 (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA, USA). After wash-
ing three times with TBST washing buffer (TBS with 
1% Tween-20) for 20 minutes each, the membranes 
were incubated with horseradish peroxidase-labeled 
secondary antibodies (goat anti-rabbit antibody) for 
1 hour. Finally, they were washed three times with 
TBST washing buffer for 20 minutes each, and de-
tection was performed using the enhanced chemi-
luminescence Western blotting detection system 
(Pierce Biotechnology, Inc., Rockford, IL, USA).
2.6. Statistical analysis
Data are presented as mean ± standard deviation. 
Significant differences were assessed using the 
Wilcoxon signed rank test. A p value less than 0.05 
was considered statistically significant. SigmaStat 
software (Jandel Scientific, Erkrath, Germany) was 
used for all statistical analyses.
3. Results
3.1.  Osthol suppressed IL-4-induced 
eotaxin production in BEAS-2B cells 
in a dose-dependent manner
The viability of BEAS-2B cells with different osthol 
treatments was around 90%. There was no obvious 
difference between the control and treated cells. 
Osthol (1−10 μM) significantly downregulated IL-4-
induced eotaxin production in BEAS-2B cells in a 
dose-dependent manner (37.86 ± 7.24 pg/mL in IL-4-
treated vs. 18.50 ± 11.29 pg/mL in IL-4 plus osthol 
10 μM, p = 0.028) (Figure 1). TNF-α enhanced IL-4-
induced eotaxin production in BEAS-2B cells. Osthol 
also suppressed IL-4- and TNF-α-induced eotaxin 
expression of BEAS-2B cells in a dose-dependent 
manner (352.72 ± 42.27 pg/mL in IL-4- and TNF-α-
treated vs. 115.02 ± 63.02 pg/mL in IL-4 and TNF-α 
plus osthol 10 μM, p = 0.028) (Figure 2). A lower dose 
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Figure 1 BEAS-2B cells were pretreated with osthol 2 
hours before IL-4 stimulation. Cell supernatant was col-
lected for measurement of eotaxin concentration after 
IL-4 stimulation for 48 hours. Effect of osthol at three 
different concentrations (0.1, 1, 10 μM) on the release of 
eotaxin in BEAS-2B cells: osthol (0.1−10 μM) suppressed 
IL-4 (20 ng/mL)-induced eotaxin expression in BEAS-2B 
cells. These data represent the average values of three 
repeated studies. *p < 0.05.
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of osthol (0.1 μM) had no effect on IL-4-induced, or 
on IL-4- and TNF-α-induced eotaxin production in 
BEAS-2B cells.
3.2.  Osthol suppressed IL-4-induced 
eotaxin mRNA expression in 
BEAS-2B cells
Osthol suppressed expression of eotaxin mRNA 
in BEAS-2B cells in a dose-dependent manner 
(53.16 ± 17.99 in IL-4-treated vs. 3.54 ± 0.81 in 
IL-4 plus osthol 10 μM, p = 0.03) (Figure 3). These 
results were in accordance with those for protein 
expression.
3.3.  Osthol suppressed IL-4-induced STAT6 
expression in BEAS-2B cells
The IL-4 and IL-4 receptor (IL-4R) interaction can 
potentiate either JAK or MAPK cascades, and con-
sequently activate STAT6. To further confirm if the 
three members of the MAPK pathway, p38, ERK and 
JNK, were involved in the suppression of IL-4-induced 
eotaxin expression in BEAS-2B cells by osthol, we 
used Western blotting to detect protein expression. 
Osthol suppressed IL-4-induced STAT6 phosphoryla-
tion (Figure 4A), but did not interfere with the 
phosphorylation of JNK, p38 or ERK in BEAS-2B 
cells (Figures 4B−D).
4. Discussion
Gradual increases in the prevalence of asthma and 
allergic diseases have been reported in industrial-
ized countries during the last 20−30 years.15 Allergic 
asthma may result from an inappropriate immune 
response to inhaled allergens and is characterized 
by the recruitment of eosinophils, lymphocytes, and 
neutrophils to the lung, inflammatory mediator re-
lease, IgE production, mucin hypersecretion and 
bronchoconstriction. CD4+ Th2-type cells mediate 
these responses through the production of the cyto-
kines IL-4, IL-5, IL-9 and IL-13.16 Asthma is a chronic 
inflammatory disease of the airways characterized 
by airway obstruction, epithelial cell damage and 
airway hyperresponsiveness.17 Although corticoster-
oids, together with other existing drugs (β2 receptor 
agonists and oral leukotriene receptor antagonists) 
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Figure 3 BEAS-2B cells were pretreated with osthol 2 hours before IL-4 stimulation for 6 hours. (A) Total RNA was 
extracted, and its expression was measured using real-time PCR. Osthol suppressed eotaxin mRNA expression in 
BEAS-2B cells. (B) Results are expressed as the arithmetic mean ± standard error of the mean from three independent 
experiments. These data represent the average values of three repeated studies. *p < 0.05 when compared between 
groups denoted by the horizontal lines.
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Figure 2 BEAS-2B cells were pretreated with osthol 2 
hours before IL-4 and TNF-α stimulation. Cell supernatant 
was collected for measurement of eotaxin concentration 
after IL-4 stimulation for 48 hours. IL-4- and TNF-α- 
induced eotaxin expression in BEAS-2B cells: eotaxin 
production was reduced by osthol (0.1−10 μM) in a dose-
dependent manner. These data represent the average 
values of three repeated studies. *p < 0.05.
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influence many different inflammatory cell types 
and continue to be the gold standard for therapy in 
asthma today,18 many thousands of sufferers have 
“steroid phobia”, especially in the Far East. There 
remains a clear need for novel approaches to ther-
apy or prophylaxis, particularly in the target organ 
where airway inflammation occurs.
Over the last few decades, a global resurgence 
in the use of herbal remedies has fuelled the multi-
billion dollar international trade in botanical pro-
ducts. Many patients, dissatisfied with classical 
medicines because they expect permanent cures, 
believe that herbal remedies are “natural”, and they 
self-medicate without informing their attending 
physician. Although there is a long history of use of 
traditional Chinese herbs to treat various diseases, 
no studies have assessed the use of the Chinese 
herb extract, osthol, on the allergic inflammation of 
bronchial epithelial cells, which mimics the clinical 
condition of asthma.
The inflammatory and airway remodeling proc-
esses in asthma are the consequence of highly com-
plex interactions among inflammatory cells such 
as eosinophils, activated T-cells, mast cells, and 
macrophages, with structural tissue cells including 
the bronchial epithelium, endothelial cells and fi-
broblasts.19 Eosinophils are important inflammatory 
effector cells that accumulate at the site of aller-
gic inflammation, e.g., the airway submucosa.20 The 
activated eosinophils release cytotoxic molecules 
such as major basic proteins, eosinophil peroxidase, 
eosinophilic cationic protein, lipid mediators and 
cytokines that cause tissue damage and consequently 
result in the manifestations of allergic diseases, e.g., 
allergic asthma. The interaction of bronchial epithe-
lium with eosinophils represents a crucial mechanism 
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Figure 4 BEAS-2B cells were pretreated with osthol 2 hours before IL-4 stimulation for 30 minutes. Cell lysates were 
used for Western blotting. (A) Osthol suppressed IL-4-induced STAT6. There was no effect of osthol on IL-4-induced phos-
phorylation of: (B) JNK, (C) p38 or (D) ERK in BEAS-2B cells. Results are representative of four independent experiments.
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in the initiation of local inflammation in allergic 
asthma. In this study, we examined the release of 
the inflammatory chemokine eotaxin, stimulated 
by the Th2 cytokine, IL-4, which mimics the in vivo 
conditions in bronchial allergic asthma. The sup-
pressive effect of osthol on IL-4-induced eotaxin 
expression demonstrated in our study suggests that 
osthol may be of benefit in allergic diseases. Osthol 
suppressed eotaxin protein expression at 1−10 μM, 
but suppressed mRNA production at 0.1−10 μM. Our 
findings suggest that the mechanism of suppression 
may involve post-transcriptional modification.
The IL-4 and IL-4R interaction potentiates either 
the JAK or MAPK cascades and, consequently, acti-
vates STAT6.21 MAPKs, a family of serine/threonine 
kinases, are mediators of intracellular signals in re-
sponse to various stimuli. MAPKs have demonstrated 
involvement in the regulation of many cellular phys-
ical functions, including proliferation, differentia-
tion, inflammation, and apoptosis.22 STAT6 is the 
sole STAT protein capable of transducing signals from 
IL-4R. Upon activation, STAT6 dimerizes, translo-
cates to the nucleus, and binds to specific pro-
moter regions to regulate gene transcription.23 In 
the present study, we showed that pretreatment 
with osthol inhibited eotaxin production in BEAS-2B 
cells in a dose-dependent manner after stimulation 
with IL-4 alone, or when combined with TNF-α, and 
this was related to the recruitment of eosinophils 
associated with asthma, as shown by ELISA. In our 
study, MAPK expression was not obviously sup-
pressed (as shown by Western blotting), and the 
mechanism of action might therefore be through 
decreased IL-4R-JAK-STAT6 expression, rather than 
through the MAPK pathway. The toxicities of osthol 
include convulsion, muscle contraction and spas-
ticity.6 In animal studies, a lethal dose (LD50) is 40−
190 mg/kg, and the therapeutic dose is about 9 mg/
kg.24 There are no results from clinical studies.
In conclusion, this is the first study to assess the 
effects of the Chinese herb extract osthol on BEAS-2B 
cells, which mimic the clinical conditions of asthma. 
The findings of this study suggest that osthol may 
be of potential use in the treatment of allergic air-
way disease, though its clinical use needs to be 
further investigated.
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